The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee today by a unanimous vote recommended that the FDA issue an emergency use authorization that would enable COVID-19 vaccine boosters for individuals age 65 and older and those at high risk for severe COVID-19, administered at least six months after a completed initial two-dose mRNA regimen.

The panel then weighed whether “high risk” included occupational exposure, which includes health care workers. FDA has the ability to accept or decline the panel’s recommendations, which are non-binding.

The panel had earlier voted by a wide margin not to recommend COVID-19 vaccine booster shots for the broader vaccinated public under Pfizer’s application to add a third, booster dose to its approved two-dose regimen. 

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices next week will also consider the question of boosters’ necessity; it is expected that ACIP will conduct additional discussion around whether health care workers are included within the high-risk category.
 

Related News Articles

Headline
The Centers for Disease Control and Prevention last week updated the list of underlying medical conditions that put adults of any age at higher risk for…
Headline
Abbott Molecular Inc. yesterday issued a recall for its Alinity m SARS-CoV-2 AMP Kits and Alinity m Resp-4-Plex AMP Kits, distributed between May 13, 2020, and…
Headline
The Centers for Disease Control and Prevention yesterday released an operational planning guide for pediatric COVID-19 vaccination and preliminary information…
Headline
Available data support the safety and effectiveness of the Johnson & Johnson COVID-19 vaccine for emergency use authorization as a booster dose in…
Headline
A Food and Drug Administration advisory panel today voted unanimously to recommend an extra Moderna booster dose for certain individuals. The Vaccines and…
Headline
The AHA today launched a new video series, Vaccines Work, highlighting all the successful vaccines that have helped fight severe disease and illness, such as…